JPH08133959A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPH08133959A JPH08133959A JP6298751A JP29875194A JPH08133959A JP H08133959 A JPH08133959 A JP H08133959A JP 6298751 A JP6298751 A JP 6298751A JP 29875194 A JP29875194 A JP 29875194A JP H08133959 A JPH08133959 A JP H08133959A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- effect
- acid
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 34
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 11
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960002298 aminohydroxybutyric acid Drugs 0.000 claims abstract description 9
- 210000002966 serum Anatomy 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 7
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 241001282048 Cotoneaster pannosus Species 0.000 claims description 9
- 235000003105 Pyracantha coccinea Nutrition 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 235000004789 Rosa xanthina Nutrition 0.000 claims description 4
- 241000220222 Rosaceae Species 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 28
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 abstract description 5
- 229950009883 tocopheryl nicotinate Drugs 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 241001295689 Pyracantha Species 0.000 abstract 1
- 241001295692 Pyracantha fortuneana Species 0.000 abstract 1
- 244000184734 Pyrus japonica Species 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 48
- 238000012360 testing method Methods 0.000 description 13
- 230000003405 preventing effect Effects 0.000 description 10
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 102000011782 Keratins Human genes 0.000 description 7
- 108010076876 Keratins Proteins 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 230000007306 turnover Effects 0.000 description 4
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000002884 skin cream Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- JGHSBPIZNUXPLA-UHFFFAOYSA-N 2-hydroxyhexadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)C(O)=O JGHSBPIZNUXPLA-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003544 deproteinization Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000000687 hydroquinonyl group Chemical class C1(O)=C(C=C(O)C=C1)* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007788 roughening Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-hydroxyoctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、色黒の皮膚を予防し、
色黒の皮膚を速やかに淡色化し、優れた肌荒れ防止効
果、角質改善効果、老化防止効果及び美肌効果を発現
し、皮膚を健やかに保つことのできる皮膚化粧料に関す
る。FIELD OF THE INVENTION The present invention prevents dark skin,
The present invention relates to a skin cosmetic capable of rapidly lightening dark skin, exhibiting an excellent effect of preventing rough skin, an effect of improving keratin, an effect of preventing aging and an effect of beautiful skin, and keeping the skin healthy.
【0002】[0002]
【従来技術及び発明が解決しようとする課題】従来よ
り、肌のしみやそばかす等の予防や治療を目的とする美
白化粧料には、L−アスコルビン酸およびその誘導体、
ハイドロキノン誘導体、コウジ酸等のピロン類、プラセ
ンターエキス等の胎盤抽出物が配合されている。BACKGROUND OF THE INVENTION Conventionally, whitening cosmetics for the purpose of preventing or treating spots and freckles on the skin include L-ascorbic acid and its derivatives,
Hydroquinone derivatives, pyrones such as kojic acid, and placenta extracts such as placenta extract are included.
【0003】これらの物質は、メラニン生成の抑制、生
成したメラニンの淡色漂白作用等の効果を有し、美白効
果を有する物質として広く知られている。しかし、これ
らの物質を単独で使用した場合、例えばL−アスコルビ
ン酸およびその誘導体を配合するとき、保存安定性が十
分でなくその効果が十分に発揮されなかったり、ハイド
ロキノン誘導体は安全性に問題があるなど十分満足され
るものではなかった。These substances are widely known as substances having a whitening effect because they have the effects of suppressing the production of melanin, light-color bleaching action of the produced melanin and the like. However, when these substances are used alone, for example, when L-ascorbic acid and its derivative are blended, the storage stability is insufficient and the effect is not sufficiently exerted, and the hydroquinone derivative has a safety problem. I was not completely satisfied.
【0004】中国名「火棘」の果実は漢方名「赤陽子」
として、脾臓を健やかに保つ、消化不良の治療等の薬効
を持つことが知られている。また、さらに、これはチロ
シナーゼ活性阻害効果やメラニン生成抑制効果を持ち、
この抽出物を配合した美白用化粧料が提案されている
(特開平5−58870号公報)。しかし、これを単独
で配合したものは、チロシナーゼ活性阻害効果、メラニ
ン生成抑制効果はみとめられるが、肌荒れ防止効果、角
質改善効果、老化防止効果は認められない。このよう
に、色黒の皮膚を予防し、色黒の皮膚を速やかに淡色化
し、すぐれた肌荒れ防止効果、角質改善効果、老化防止
効果及び美肌効果を発現し、皮膚を健やかに保つことの
できる皮膚化粧料はまだ開発されていないというのが実
状である。The fruit of the Chinese name "fire thorn" is the Chinese name "red proton"
As, it is known to have a medicinal effect such as keeping the spleen healthy and treating indigestion. In addition, it has tyrosinase activity inhibitory effect and melanin production inhibitory effect,
A whitening cosmetic composition containing this extract has been proposed (JP-A-5-58870). However, the thyrosinase activity-inhibiting effect and the melanin production-inhibiting effect of the mixture containing these alone are not observed, but the rough skin preventing effect, the keratin improving effect and the aging preventing effect are not recognized. In this way, it is possible to prevent dark skin, lighten the dark skin quickly, develop an excellent skin roughening prevention effect, keratin improving effect, anti-aging effect and beautiful skin effect, and keep the skin healthy. The reality is that skin cosmetics have not yet been developed.
【0005】そこで本発明者はこのような状況に鑑み、
鋭意研究した結果、血清除蛋白物、炭素数2から18の
α−ヒドロキシカルボン酸、センブリエキス、ビタミン
E−ニコチネート、ジイソプロピルアミンジクロロアセ
テート、γ−アミノ酪酸、γ−アミノ−β−ヒドロキシ
酪酸およびその塩から選ばれる1種又は2種以上と、バ
ラ科ピラカンタ属の一種である中国名「火棘」の果実の
溶媒抽出物を含有する皮膚化粧料は、表皮に存在する
メラニンを速やかに排除し、新たに皮膚内にメラニン
が生成することを抑制するなど、優れた美白効果を有
し、血行促進作用又は細胞賦活作用を有する成分と火棘
からの抽出物中に含まれる保湿成分の相乗作用により、
優れた肌荒れ防止効果、角質改善効果、老化防止効果及
び美肌効果を発現することを見出し、本発明を完成する
に至った。Therefore, in view of such a situation, the present inventor has considered
As a result of intensive research, serum deproteinization, α-hydroxycarboxylic acid having 2 to 18 carbon atoms, assembly extract, vitamin E-nicotinate, diisopropylamine dichloroacetate, γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid and the Dermocosmetics containing one or more selected from salts and a solvent extract of the fruit of the Chinese name "Fire spine" which is one of the genus Pyracanta in the family Rosaceae quickly eliminates melanin present in the epidermis. , Synergistic action of a component that has an excellent whitening effect such as newly suppressing the formation of melanin in the skin and has a blood circulation promoting action or a cell activating action and a moisturizing component contained in the extract from fire thorns. Due to
The inventors have found that they exhibit an excellent effect of preventing rough skin, an effect of improving keratin, an effect of preventing aging and an effect of beautiful skin, and have completed the present invention.
【0006】本発明の目的は、色黒の皮膚を予防し、色
黒の皮膚を速やかに淡色化する効果を有し、また優れた
肌荒れ防止効果、角質改善効果、老化防止効果及び美肌
効果を有し、皮膚を健やかに保つことのできる皮膚化粧
料を提供することにある。The object of the present invention is to prevent dark skin and to lighten dark skin quickly, and also to provide excellent skin roughening prevention effect, keratin improving effect, anti-aging effect and beautiful skin effect. An object of the present invention is to provide a skin cosmetic that has and keeps the skin healthy.
【0007】[0007]
【課題を解決するための手段】上記目的を達成する本発
明は、血清除蛋白物、炭素数2から18のα−ヒドロキ
シカルボン酸、センブリエキス、ビタミンE−ニコチネ
ート、ジイソプロピルアミンジクロロアセテート、γ−
アミノ酪酸、γ−アミノ−β−ヒドロキシ酪酸およびそ
の塩からなる群から選択された少なくとも一種と、バラ
科ピラカンタ属(Rosaceae Pyracant
ha)の一種である中国名「火棘」(Pyracant
ha fortuneana)の果実の溶媒抽出物を含
有する皮膚化粧料である。Means for Solving the Problems The present invention which achieves the above-mentioned object is to provide a serum deproteinized product, α-hydroxycarboxylic acid having 2 to 18 carbon atoms, cembly extract, vitamin E-nicotinate, diisopropylamine dichloroacetate, γ-.
At least one selected from the group consisting of aminobutyric acid, γ-amino-β-hydroxybutyric acid, and salts thereof, and a genus Rosaceae Pyracant
Ha) is a kind of Chinese name "Pyracant"
It is a skin cosmetic containing a solvent extract of the fruit of ha fortuneana).
【0008】以下、本発明の構成について詳述する。本
発明に用いられる血清除蛋白物は、幼牛などの血液、血
清、リンパ液、胎盤抽出液などを原料とすることができ
る。これらの原料から、除蛋白処理、低温処理、脂溶性
成分除去処理など、常法に従い目的の抽出物を得る。得
られた抽出物は4〜5%固形物を有し、有機物として分
子量3000以下のペプチド、アミノ酸、有機酸、糖質
などを含有しており、ミトコンドリアの呼吸能賦活によ
る組織呼吸促進作用に優れ、高い保湿性を有している。
これらの抽出物は、ソルコセリル(ソルコバーゼル社
製)またはエスアール71(BOTTGER社製)とし
て購入することができる。The structure of the present invention will be described in detail below. The serum deproteinized protein used in the present invention can be made from blood such as calf, serum, lymph, placenta extract, and the like. From these raw materials, the target extract is obtained by a conventional method such as deproteinization treatment, low temperature treatment, and fat-soluble component removal treatment. The obtained extract has a solid content of 4 to 5%, contains peptides having a molecular weight of 3000 or less, amino acids, organic acids, sugars, etc. as an organic substance, and is excellent in the tissue respiration promoting action by activating mitochondrial respiratory ability. , Has a high moisturizing property.
These extracts can be purchased as Solcoceryl (manufactured by Solco Basel) or S-71 (manufactured by BOTTGER).
【0009】血清除蛋白物の含有量は、乾燥固形物量と
して、化粧料の処方成分全量を基準として好ましくは
0.0001〜0.5重量%、さらに好ましくは0.0
01〜0.1重量%の範囲内である。The content of the serum deproteinized product is preferably 0.0001 to 0.5% by weight, more preferably 0.00% by weight, as a dry solid content, based on the total amount of the prescription components of the cosmetic composition.
It is within the range of 01 to 0.1% by weight.
【0010】本発明に用いられるα−ヒドロキシカルボ
ン酸としては、炭素数2から18であれば特に限定され
ることはないが、例えば、グリコール酸、乳酸、乳酸ナ
トリウム、クエン酸、クエン酸ナトリウム、リンゴ酸、
酒石酸、α−ヒドロキシオクタン酸、α−ヒドロキシパ
ルミチン酸、α−ヒドロキシステアリン酸などが挙げら
れ、その中でも炭素数2から8のものが好ましい。The α-hydroxycarboxylic acid used in the present invention is not particularly limited as long as it has 2 to 18 carbon atoms. For example, glycolic acid, lactic acid, sodium lactate, citric acid, sodium citrate, Malic acid,
Examples thereof include tartaric acid, α-hydroxyoctanoic acid, α-hydroxypalmitic acid and α-hydroxystearic acid, and among them, those having 2 to 8 carbon atoms are preferable.
【0011】その配合量は、好ましくは化粧料全量中
0.01〜20重量%である。The blending amount thereof is preferably 0.01 to 20% by weight based on the total amount of the cosmetic.
【0012】本発明に用いられるセンブリエキスの製造
法に関しては特定されるものではないが、概要は下記の
通りである。The method for producing the assembly extract used in the present invention is not specified, but the outline is as follows.
【0013】[センブリエキスの製造法]センブリ(S
wertia Japonica Makino)の開
花期全草の乾燥粉砕物をエタノールあるいは含水エタノ
ール中で温浸し、濾別して得られた抽出液である。実施
例には、下記の方法で得られた抽出液を利用した。[Method for producing assembly extract] Assembly (S
(Wertia Japana Makino) is an extract obtained by digesting a dried and pulverized whole plant of flowering whole plants in ethanol or hydrous ethanol and filtering. The extract obtained by the following method was used in the examples.
【0014】センブリ細砕物50gを含水エタノール
(エタノール90wt%)250mlに温度40〜50
℃で温浸して濾別した後、再び残渣を同様に温浸するこ
とを数回繰り返し、抽出液1.5lを得た。これを減圧
濃縮した残留物に精製水を100ml加え、1週間熟成
した後、不溶物を濾別して得た抽出液を減圧濃縮し、つ
いでエタノールを加えて抽出液のエタノール含有量が4
0wt%になるように調製し、100mlのセンブリエ
キスを得た。50 g of crushed assembly product was added to 250 ml of water-containing ethanol (90 wt% of ethanol) at a temperature of 40-50.
After the mixture was digested at ℃ and filtered, the residue was digested again in the same manner several times to obtain 1.5 liters of the extract. 100 ml of purified water was added to the residue obtained by concentration under reduced pressure, the mixture was aged for 1 week, the insoluble material was filtered off, and the obtained extract was concentrated under reduced pressure. Then, ethanol was added to the extract so that the ethanol content was 4%.
It was adjusted to be 0 wt% to obtain 100 ml of seaweed extract.
【0015】本発明に用いられるγ−アミノ−β−ヒド
ロキシ酪酸塩としては、γ−アミノ−β−ヒドロキシ酪
酸を苛性カリ、苛性ソーダ、または水酸化カルシウム、
水酸化マグネシウムで中和したγ−アミノ−β−ヒドロ
キシ酪酸のカリウム塩、同ナトリウム塩、同カルシウム
塩、同マグネシウム塩が挙げられ、いずれもγ−アミノ
−β−ヒドロキシ酪酸と同程度の血行促進作用又は細胞
賦活作用を有する。As the γ-amino-β-hydroxybutyric acid salt used in the present invention, γ-amino-β-hydroxybutyric acid is caustic potash, caustic soda, or calcium hydroxide,
Examples include potassium salt, sodium salt, calcium salt, and magnesium salt of γ-amino-β-hydroxybutyric acid neutralized with magnesium hydroxide, all of which promote blood circulation to the same extent as γ-amino-β-hydroxybutyric acid. It has an action or a cell activation action.
【0016】本発明に用いられるセンブリエキス、ビタ
ミンE−ニコチネート、ジイソプロピルアミンジクロロ
アセテート、γ−アミノ酪酸、γ−アミノ−β−ヒドロ
キシ酪酸およびその塩の望ましい配合量は表1の通りで
ある。The desirable compounding amounts of the assembly extract, vitamin E-nicotinate, diisopropylamine dichloroacetate, γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid and salts thereof used in the present invention are shown in Table 1.
【0017】[0017]
【表1】 [Table 1]
【0018】本発明に用いられる中国名「火棘」の果実
である漢方名「赤陽子」の有効成分(以下「火棘抽出
物」と略記する)は、水またはメタノール、エタノー
ル、プロパノール等の低級アルコール、またはそれらの
混液により抽出される。抽出液はそのまま化粧料に配合
することも可能であるが、これを凍結乾燥法やスプレー
ドライ法等で粉末化して使用するほうがが好ましい。ま
た、抽出液を液液分配、吸着クロマトグラフィー等の手
段で精製して、液状のものあるいは粉末化したものを配
合することも可能である。The active ingredient (hereinafter abbreviated as "fire thorn extract") of the Chinese medicine name "red proton" which is a fruit of Chinese name "fire thorn" used in the present invention is water or methanol, ethanol, propanol and the like. It is extracted with a lower alcohol or a mixed solution thereof. The extract can be directly blended in cosmetics, but it is preferable to use it by pulverizing it by a freeze-drying method or a spray-drying method. It is also possible to mix the liquid or powdered product by purifying the extract liquid by means of liquid-liquid distribution, adsorption chromatography or the like.
【0019】その配合量は化粧料全量中、抽出物に換算
して0.001〜5重量%が好ましく、更に好ましくは
0.01〜2重量%である。The blending amount thereof is preferably 0.001 to 5% by weight, more preferably 0.01 to 2% by weight in terms of extract based on the total amount of the cosmetic.
【0020】本発明の化粧料には、上記原料の他に、色
素、香料、防腐剤、界面活性剤、顔料、抗酸化剤、保湿
剤、紫外線吸収剤などを、本発明の目的を達成する範囲
内で適宜配合することができる。In the cosmetic of the present invention, in addition to the above-mentioned raw materials, pigments, fragrances, preservatives, surfactants, pigments, antioxidants, humectants, ultraviolet absorbers, etc. are achieved to achieve the object of the present invention. It can be appropriately blended within the range.
【0021】本発明の化粧料の剤型としては、クリー
ム、乳液、化粧水、パック、デイエッセンスなどが挙げ
られる。この化粧料は、例えば乳液等の場合、油相及び
水相をそれぞれ加熱溶解したものを乳化分散して冷却す
る通常の方法により製造することができる。Examples of the dosage form of the cosmetic of the present invention include cream, emulsion, lotion, pack, day essence and the like. For example, in the case of an emulsion or the like, this cosmetic can be produced by an ordinary method of emulsifying and dispersing an oily phase and an aqueous phase, which are dissolved by heating, and cooling.
【0022】[0022]
【実施例】以下、実施例及び比較例に基づいて本発明を
詳述する。尚、実施例に示す%とは重量%である。実施
例に記載の皮膚色明度回復試験法、角質層のターンオー
バー速度測定方法(老化防止効果)、荒れ肌改善効果の
測定法、官能テスト(美肌効果は下記の通りである。ま
た、以下実施例で用いた火棘の抽出物の調製方法は以下
の通りである。EXAMPLES The present invention will be described in detail below based on examples and comparative examples. In addition,% shown in the examples is% by weight. Skin color lightness recovery test method described in Examples, method for measuring turnover rate of stratum corneum (anti-aging effect), method for measuring rough skin improving effect, sensory test (skin beautiful effect is as follows. The method for preparing the fire thorn extract used in Step 1 is as follows.
【0023】(火棘抽出物の調製法)火棘の乾燥果実
5.00gを90℃の熱水50mlに浸漬し、3時間煮
沸の後に濾過し、得られた抽出液をダイヤイオンHP−
20(三菱化成工業(株)製)のカラム(φ3cm×1
1cm、Vt=80ml)に負荷後、800mlの10
%エタノール水溶液で洗浄した。ついで、400mlの
40%エタノール水溶液で溶出し、溶出液を減圧濃縮し
た後、凍結乾燥して固形物1.04gを得た。(Preparation method of fire thorn extract) 5.00 g of dried fruits of fire thorn are immersed in 50 ml of hot water at 90 ° C., boiled for 3 hours and then filtered, and the obtained extract is Diaion HP-
20 (Mitsubishi Chemical Industries Co., Ltd.) column (φ3 cm × 1)
1 cm, Vt = 80 ml), then 800 ml of 10
% Aqueous solution of ethanol. Then, it was eluted with 400 ml of 40% aqueous ethanol solution, the eluate was concentrated under reduced pressure, and then freeze-dried to obtain 1.04 g of a solid matter.
【0024】(1)皮膚色明度回復試験法 被験者20名の背部皮膚にUV−B領域の紫外線を最小
紅斑量の2倍照射し、試料塗布部位と非塗布部位を設定
して各々の皮膚の基準明度(V0 値、V0 ´値)を測定
した。引き続いて塗布部位には試料を1日2回ずつ15
週間連続塗布した後、3、6、9、12、15週間後の
塗布部位及び非塗布部位の皮膚の明度(Vn 値、Vn ´
値)を測定し、下記の判定基準にしたがって皮膚色の回
復を評価した。尚、皮膚の明度(マンセル表色系V値)
は高速分光色彩計で測定して得られたX、Y、Z値より
算出した。また評価は被験者20名ついて、3週間後の
評価点の平均値で示した。 (1) Skin color lightness recovery test method The back skin of 20 subjects was irradiated with ultraviolet rays in the UV-B region at twice the minimum erythema dose, and a sample application site and a non-application site were set to determine the skin of each skin. The standard lightness (V0 value, V0 'value) was measured. Subsequently, the sample is applied to the application site twice a day 15 times.
Lightness (Vn value, Vn 'of the skin at the application site and non-application site after 3, 6, 9, 12, 15 weeks after continuous application for a week
Value) was measured and the recovery of skin color was evaluated according to the following criteria. The brightness of the skin (V value of Munsell color system)
Was calculated from X, Y, and Z values obtained by measurement with a high-speed spectrocolorimeter. The evaluation was shown by the average value of the evaluation points after 3 weeks for 20 subjects.
【0025】(2)角質層のターンオーバー速度測定 蛍光色素のダンシルクロライドを白色ワセリン中に5重
量%配合した軟膏を作り、被験者の前腕部の皮膚に24
時間閉塞貼布し、角質層にダンシルクロライドを浸透結
合する。その後同じ部位に1日2回(朝、夕)被験試料
を塗布し、毎日ダンシルクロライドの蛍光を調べ、その
蛍光が消滅するまでの日数を皮膚角質のターンオーバー
速度とした。なお、通常の皮膚角質層のターンオーバー
速度は、14〜16日であるが、老化した皮膚において
は18日前後に延び、それに対して老化防止効果が現れ
ると12日前後にまで短縮される。(2) Measurement of turnover rate of stratum corneum An ointment was prepared by adding 5% by weight of a fluorescent dye, dansyl chloride, to white petrolatum and applied to the skin of the forearm of a subject.
Apply occluded for a time and permeate dansyl chloride into the stratum corneum. Thereafter, the test sample was applied to the same site twice a day (morning and evening), and the fluorescence of dansyl chloride was examined every day. The number of days until the fluorescence disappeared was defined as the turnover rate of the skin keratin. The normal turnover rate of the stratum corneum of the skin is 14 to 16 days, but in aged skin, it extends to around 18 days, and when the antiaging effect appears, it is shortened to around 12 days.
【0026】(3)荒れ肌改善効果の測定試験法 下脚に荒れ肌を有する中高年被験者20名を対象として
4週間連続塗布効果を調べた。被験者の左側下脚試験部
位に1日2回約1gの試料を塗布し、試験開始前及び終
了後の皮膚の状態を下記の判定基準により判定した。右
側下脚は試料を塗布せず対照とした。 試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば;+→
−、++→±)を「有効」、1段階改善された場合を
「やや有効」、変化がなかった場合を「無効」とした。
試験結果は「有効」「やや有効」となった被験者の人数
で示した。(3) Method for measuring the effect of improving rough skin The effect of continuous application for 4 weeks was examined on 20 middle-aged and elderly subjects who have rough skin on their lower legs. About 1 g of the sample was applied to the left lower leg test site of the test subject twice a day, and the condition of the skin before and after the start of the test was evaluated according to the following criteria. The lower right leg was not coated with the sample and served as a control. If the skin dryness is improved by two or more levels by comparing the judgment results of the test site before and after the test and the control site (eg; + →
−, ++ → ±) was defined as “valid”, a case of improvement by 1 level was defined as “slightly valid”, and a case of no change was defined as “invalid”.
The test results are shown by the number of subjects who were “valid” and “somewhat valid”.
【0027】(4)官能試験 被験者20名が試料を10日間連用した後の試料の特性
を評価した。評価は、平滑性、美白効果、弾力性のアン
ケート項目に対し、「皮膚が滑らかになった」、「美白
効果が感じられた」、「皮膚に張りが生じた」と回答し
た人数で示した。(4) Sensory test Twenty test subjects evaluated the characteristics of the sample after continuously using the sample for 10 days. The evaluation was shown by the number of respondents who answered "skin became smooth", "a whitening effect was felt", and "tension occurred on the skin" for questionnaire items of smoothness, whitening effect, and elasticity. .
【0028】実施例1〜15、比較例1〜13 血清除蛋白物、炭素数2から18であるα−ヒドロキシ
カルボン酸、センブリエキス、ビタミンE−ニコチネー
ト、ジイソプロピルアミンジクロロアセテート、γ−ア
ミノ酪酸、γ−アミノ−β−ヒドロキシ酪酸およびその
塩から選ばれる血行促進作用又は細胞賦活作用を有する
成分と、火棘抽出物を表2の組成において配合し、下記
の調製方法に基づいてスキンクリームを調製した。Examples 1 to 15 and Comparative Examples 1 to 13 Serum deproteinized products, α-hydroxycarboxylic acid having 2 to 18 carbon atoms, assembly extract, vitamin E-nicotinate, diisopropylamine dichloroacetate, γ-aminobutyric acid, A component having a blood circulation promoting action or a cell activating action selected from γ-amino-β-hydroxybutyric acid and a salt thereof and a fire thorn extract are mixed in the composition of Table 2, and a skin cream is prepared based on the following preparation method. did.
【0029】組成Composition
【表2】 [Table 2]
【0030】調製方法 (A)(B)を70℃にて均一に溶解し、(A)を攪拌
しながら(B)を(A)に注入して乳化分散した後、攪
拌しながら温度30℃まで冷却して調製する。このよう
にして調製された皮膚化粧料を試料として上記評価試験
によって試験を行った結果を表3、4に示す。Preparation Method (A) and (B) are uniformly dissolved at 70 ° C., (A) is stirred and (B) is poured into (A) to emulsify and disperse, and then the temperature is stirred at 30 ° C. Cool to prepare. Tables 3 and 4 show the results of tests conducted by the above-mentioned evaluation test using the skin cosmetics thus prepared as samples.
【0031】[0031]
【表3】 [Table 3]
【0032】[0032]
【表4】 [Table 4]
【0033】特性本発明の実施例1〜15のスキンク
リームは、前記諸試験において良好な結果を示した。一
方、比較例1〜13のスキンクリームは、十分な効果が
認められず、本発明の実施例に比べて劣っていた。Properties The skin creams of Examples 1 to 15 of the present invention showed good results in the above tests. On the other hand, the skin creams of Comparative Examples 1 to 13 were inferior to those of the examples of the present invention because sufficient effects were not recognized.
【0034】[0034]
【発明の効果】以上記載のごとく、本発明が、色黒の皮
膚を予防し、色黒の皮膚を速やかに淡色化する効果を有
し、さらに優れた肌荒れ防止効果、角質改善効果、老化
防止効果及び美肌効果を発現し、皮膚を健やかに保つこ
とのできる優れた皮膚化粧料を提供することは明らかで
ある。INDUSTRIAL APPLICABILITY As described above, the present invention has the effects of preventing dark skin and rapidly lightening dark skin, and further has excellent effects of preventing rough skin, improving keratin and preventing aging. It is obvious to provide an excellent skin cosmetic which exhibits the effect and the skin beautifying effect and can keep the skin healthy.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/00 H ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display area A61K 7/00 H
Claims (2)
ヒドロキシカルボン酸、センブリエキス、ビタミンE−
ニコチネート、ジイソプロピルアミンジクロロアセテー
ト、γ−アミノ酪酸、γ−アミノ−β−ヒドロキシ酪酸
およびその塩からなる群から選択された少なくとも一種
と、バラ科ピラカンタ属(Rosaceae Pyra
cantha)の一種である中国名「火棘」(Pyra
cantha fortuneana)の果実の溶媒抽
出物を含有する皮膚化粧料。1. Serum deproteinized protein, α-containing 2 to 18 carbon atoms
Hydroxycarboxylic acid, assembly extract, vitamin E-
At least one selected from the group consisting of nicotinate, diisopropylamine dichloroacetate, γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid and salts thereof, and Rosaceae Pyracanta (Rosaceae Pyra).
cantha), which is a kind of Chinese name "Pyra"
A skin cosmetic containing a solvent extract of the fruit of cantha fortuneana).
ール、エタノール、プロパノールまたはその混液である
請求項1記載の皮膚化粧料。2. The skin cosmetic according to claim 1, wherein the extraction solvent for the "fire thorn" fruit is water, methanol, ethanol, propanol or a mixed solution thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29875194A JP3390549B2 (en) | 1994-11-07 | 1994-11-07 | Skin cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29875194A JP3390549B2 (en) | 1994-11-07 | 1994-11-07 | Skin cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08133959A true JPH08133959A (en) | 1996-05-28 |
JP3390549B2 JP3390549B2 (en) | 2003-03-24 |
Family
ID=17863770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29875194A Expired - Lifetime JP3390549B2 (en) | 1994-11-07 | 1994-11-07 | Skin cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3390549B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10194960A (en) * | 1997-01-14 | 1998-07-28 | Kanebo Ltd | Skin cosmetic |
JP2000119160A (en) * | 1998-10-06 | 2000-04-25 | Kanebo Ltd | Skin cosmetic |
US6091188A (en) * | 1997-03-31 | 2000-07-18 | Nec Corporation | Field emission cold cathode and method of fabricating the same |
JP2010077052A (en) * | 2008-09-25 | 2010-04-08 | Kao Corp | Skin cosmetic |
JP2012188417A (en) * | 2011-02-21 | 2012-10-04 | Daiichi Sankyo Healthcare Co Ltd | Inhibitor of formation of advanced glycation end product |
-
1994
- 1994-11-07 JP JP29875194A patent/JP3390549B2/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10194960A (en) * | 1997-01-14 | 1998-07-28 | Kanebo Ltd | Skin cosmetic |
US6091188A (en) * | 1997-03-31 | 2000-07-18 | Nec Corporation | Field emission cold cathode and method of fabricating the same |
JP2000119160A (en) * | 1998-10-06 | 2000-04-25 | Kanebo Ltd | Skin cosmetic |
JP2010077052A (en) * | 2008-09-25 | 2010-04-08 | Kao Corp | Skin cosmetic |
JP2012188417A (en) * | 2011-02-21 | 2012-10-04 | Daiichi Sankyo Healthcare Co Ltd | Inhibitor of formation of advanced glycation end product |
Also Published As
Publication number | Publication date |
---|---|
JP3390549B2 (en) | 2003-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000191498A (en) | Collagen production facilitative agent and preparation for external use for skin | |
JP2003300858A (en) | Skin care preparation | |
JP3389071B2 (en) | Cosmetics | |
JPH09291011A (en) | Composition suitable for eternal use | |
JP2005187474A (en) | Improved scented cosmetic | |
JP2003300824A (en) | Skin care preparation for external use for skin antiaging | |
JP2001220340A (en) | Skin preparation for external use for preventing aging | |
JP3881411B2 (en) | Composition suitable for external use | |
JP2008105984A (en) | Collagen production promoter, skin care preparation for external use, bathing agent, and food and drink | |
JP3390549B2 (en) | Skin cosmetics | |
JP3754646B2 (en) | Topical skin preparation | |
JPH06336422A (en) | External agent for skin | |
JPH0899860A (en) | Skin external agent | |
JP3885243B2 (en) | Skin cosmetics | |
JP3507635B2 (en) | Composition suitable for external use | |
JP5429851B2 (en) | Active oxygen scavenger, skin external preparation and cosmetic using the active oxygen scavenger | |
JP2010209023A (en) | Composition for beautiful skin | |
JP3140876B2 (en) | Melanin production inhibitor and external preparation for skin | |
JPH11222412A (en) | Skin preparation for external use | |
KR20020035925A (en) | Cosmetics composition comprising extract powder with vitis vinifera l.fermented solution and having whitening and anti-wrinkle effect | |
JPH09315930A (en) | Cosmetic material for skin | |
JP3635423B2 (en) | Skin cosmetics | |
JP2011207778A (en) | External preparation for skin or cosmetic | |
JPH03200708A (en) | Dermal external agent | |
JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080117 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090117 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090117 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100117 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110117 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110117 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120117 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120117 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130117 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130117 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140117 Year of fee payment: 11 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |